Bayer

Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Flag link:
Bayer Settles Roundup Lawsuit for Almost $11 Billion
Bayer Settles Roundup Lawsuit for Almost $11 Billion
Motley Fool
Bayer
Roundup
cancer
Flag link:
Big pharma heads towards important readouts
Big pharma heads towards important readouts
EP Vantage
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Flag link:
Bayer’s big kidney disease readout approaches
Bayer’s big kidney disease readout approaches
EP Vantage
Bayer
finerenone
kidney disease
clinical trials
diabetes
diabetic kidney disease
Flag link:
Bayer version of COVID-19 antimalarial hopeful may come with quality concerns: report
Bayer version of COVID-19 antimalarial hopeful may come with quality concerns: report
Fierce Pharma
Bayer
hydroxychloroquine
FDA
COVID-19
Flag link:
Merck and Bayer unveil the data behind their CV ‘success,’ underwhelming the industry
Merck and Bayer unveil the data behind their CV ‘success,’ underwhelming the industry
Endpoints
Merck
Bayer
vericiguat
clinical trials
Flag link:
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
Fierce Biotech
ACC
Merck
Bayer
heart failure
vericiguat
clinical trials
Flag link:
Bayer inks up with “small” Indian biotech for new approach at an old target
Bayer inks up with “small” Indian biotech for new approach at an old target
Endpoints
Bayer
Curadev
Takeda
R&D
India
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:
Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment
Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment
Motley Fool
Teva Pharmaceutical
Bayer
hydroxychloroquine
COVID-19
Flag link:
Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S.
Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S.
Motley Fool
Bayer
COVID-19
malaria
chloroquine
Flag link:
Bayer and MassBio teach startups regulatory ins and outs at new center
Bayer and MassBio teach startups regulatory ins and outs at new center
Fierce Pharma
regulatory
Bayer
MassBio
startups
Flag link:
Bayer picks an unconventional board chair as Wenning bails amid Roundup legal woes
Bayer picks an unconventional board chair as Wenning bails amid Roundup legal woes
Fierce Pharma
Bayer
Werner Wenning
Flag link:
Bayer, looking to grow pharmaceutical sales, seeds new research center
Bayer, looking to grow pharmaceutical sales, seeds new research center
BioPharma Dive
Bayer
Berlin
R&D
Nuvisan
Flag link:
Bayer’s Nubeqa scores key prostate cancer win in battle with Pfizer, J&J
Bayer’s Nubeqa scores key prostate cancer win in battle with Pfizer, J&J
Fierce Pharma
Bayer
Orion
Nubeqa
prostate cancer
clinical trials
Flag link:
Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup
Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup
Fierce Biotech
Joe Jimenez
Novartis
Bayer
Century Therapeutics
cell therapy
Flag link:
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
EP Vantage
Bayer
Merck
vericiguat
heart failure
AKR-001
Akero Therapeutics
clinical trials
NASH
Flag link:
Who are the 10 Most Innovative Biopharma Companies?
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Flag link:
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Flag link:
Bayer to commercialize Daré’s monthly contraceptive Ovaprene in US
Bayer to commercialize Daré’s monthly contraceptive Ovaprene in US
Pharmaceutical Business Review
Bayer
Daré Bioscience
Ovaprene
contraceptives
Flag link:

Pages